blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1385844

EP1385844 - OXAZOLIDINONES CONTAINING A SULFONIMID GROUP AS ANTIBIOTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.05.2007
Database last updated on 01.10.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[N/P]
Former [2006/27]For all designated states
AstraZeneca AB
Sodertalje
151 85 / SE
Former [2004/06]For all designated states
Astrazeneca AB
Sodertalje
151 85 / SE
Inventor(s)01 / BETTS, Michael, John
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
02 / SWAIN, Michael, Lingard
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
03 / HALES, Neil, James
35 Gatehouse Drive
Waltham, MA 02451 / US
04 / HUYNH, Hoan, Khai
35 Gatehouse Drive
Waltham, MA 02451 / US
 [2004/06]
Representative(s)Phillips, Neil Godfrey Alasdair
AstraZeneca AB
Global Intellectual Property
151 85 Sodertalje / SE
[N/P]
Former [2004/06]Phillips, Neil
AstraZeneca AB, Global Intellectual Property
151 85 Sodertalje / SE
Application number, filing date02720195.303.04.2002
[2004/06]
WO2002GB01644
Priority number, dateGB2001000876507.04.2001         Original published format: GB 0108765
US20010330588P25.10.2001         Original published format: US 330588 P
[2004/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02081470
Date:17.10.2002
Language:EN
[2002/42]
Type: A1 Application with search report 
No.:EP1385844
Date:04.02.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2002 takes the place of the publication of the European patent application.
[2004/06]
Type: B1 Patent specification 
No.:EP1385844
Date:05.07.2006
Language:EN
[2006/27]
Search report(s)International search report - published on:EP17.10.2002
ClassificationIPC:C07D413/14, A61K31/422, A61P31/04, C07D417/14
[2004/06]
CPC:
C07D413/14 (EP,US); A61P31/04 (EP); C07D417/14 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/06]
Extension statesAL07.11.2003
LT07.11.2003
LV07.11.2003
MK07.11.2003
RO07.11.2003
SI07.11.2003
TitleGerman:EINE SULFONIMID-GRUPPE ENTHALTENDE OXAZOLIDINONE ALS ANTIBIOTIKA[2004/06]
English:OXAZOLIDINONES CONTAINING A SULFONIMID GROUP AS ANTIBIOTICS[2004/06]
French:OXAZOLIDINONES CONTENANT UN GROUPE SULFONIMIDE EN TANT QU'ANTIBIOTIQUE[2004/06]
Entry into regional phase07.11.2003National basic fee paid 
07.11.2003Designation fee(s) paid 
07.11.2003Examination fee paid 
Examination procedure17.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.11.2003Examination requested  [2004/06]
27.02.2004Despatch of a communication from the examining division (Time limit: M04)
04.06.2004Reply to a communication from the examining division
29.11.2004Despatch of a communication from the examining division (Time limit: M04)
08.02.2005Reply to a communication from the examining division
27.12.2005Communication of intention to grant the patent
08.05.2006Fee for grant paid
08.05.2006Fee for publishing/printing paid
Opposition(s)10.04.2007No opposition filed within time limit [2007/24]
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
04.04.2005Renewal fee patent year 04
02.05.2006Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.07.2006
BE05.07.2006
CY05.07.2006
FI05.07.2006
NL05.07.2006
TR05.07.2006
DK05.10.2006
GR06.10.2006
PT05.12.2006
IE03.04.2007
LU03.04.2007
[2009/42]
Former [2009/38]AT05.07.2006
BE05.07.2006
CY05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
GR06.10.2006
PT05.12.2006
IE03.04.2007
LU03.04.2007
Former [2008/25]AT05.07.2006
BE05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
GR06.10.2006
PT05.12.2006
IE03.04.2007
Former [2008/21]AT05.07.2006
BE05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
GR06.10.2006
PT05.12.2006
Former [2008/04]AT05.07.2006
BE05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
PT05.12.2006
Former [2007/38]AT05.07.2006
BE05.07.2006
FI05.07.2006
IT05.07.2006
NL05.07.2006
DK05.10.2006
PT05.12.2006
Former [2007/28]AT05.07.2006
BE05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
PT05.12.2006
Former [2007/23]AT05.07.2006
FI05.07.2006
NL05.07.2006
DK05.10.2006
PT05.12.2006
Former [2007/22]FI05.07.2006
NL05.07.2006
DK05.10.2006
PT05.12.2006
Former [2007/19]FI05.07.2006
NL05.07.2006
PT05.12.2006
Former [2007/12]FI05.07.2006
PT05.12.2006
Former [2007/11]FI05.07.2006
Cited inInternational search[YD]WO9507271  (UPJOHN CO [US], et al) [YD] 1-18 * figure 2; example 6; claim 1 *;
 [AD]WO9615130  (UPJOHN CO [US], et al) [AD] 1-18 * claim 1 *;
 [AD]WO9709328  (UPJOHN CO [US], et al) [AD] 1-18* claim 1 *;
 [AD]WO9737980  (UPJOHN CO [US], et al) [AD] 1-18 * claim 1 *;
 [A]DE19707628  (MERCK PATENT GMBH [DE]) [A] 1-18 * claim 1 *;
 [AD]WO9854161  (UPJOHN CO [US], et al) [AD] 1-18 * claim 1 *;
 [YD]  - GREGORY W A ET AL, "ANTIBACTERIALS. SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF 3-ARYL-2-OXOOXAZOLIDINES. I THE B GROUP", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19890801), vol. 32, no. 8, ISSN 0022-2623, pages 1673 - 1681, XP000573960 [YD] 1-18 * table I *

DOI:   http://dx.doi.org/10.1021/jm00128a003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.